• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heart rate response to regadenoson: Making the case for its value in clinical practice.

作者信息

Andrikopoulou Efstathia, Hage Fadi G

机构信息

Division of Cardiovascular Disease, University of Alabama at Birmingham, Lyons Harrison Research Building 306, 1720 2nd AVE S, Birmingham, AL, 35294-0007, USA.

Section of Cardiology, Birmingham Veteran's Affairs Medical Center, Birmingham, AL, USA.

出版信息

J Nucl Cardiol. 2016 Jun;23(3):575-80. doi: 10.1007/s12350-015-0269-2. Epub 2015 Aug 27.

DOI:10.1007/s12350-015-0269-2
PMID:26310538
Abstract
摘要

相似文献

1
Heart rate response to regadenoson: Making the case for its value in clinical practice.瑞加诺生引起的心率反应：论证其在临床实践中的价值。
J Nucl Cardiol. 2016 Jun;23(3):575-80. doi: 10.1007/s12350-015-0269-2. Epub 2015 Aug 27.
2
Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.雷加得诺森负荷心肌灌注成像时心率反应在终末期肾病患者中的预后价值
J Nucl Cardiol. 2016 Jun;23(3):560-9. doi: 10.1007/s12350-015-0234-0. Epub 2015 Aug 22.
3
Regadenoson: a new myocardial stress agent.瑞加德松：一种新型心肌应激剂。
J Am Coll Cardiol. 2009 Sep 22;54(13):1123-30. doi: 10.1016/j.jacc.2009.04.089.
4
The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.心肌灌注成像期间对雷加曲班心率反应进行系列测量的可重复性及预后价值
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1493-502. doi: 10.1007/s00259-016-3380-y. Epub 2016 Apr 15.
5
Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance.雷加腺苷和腺苷是等效的血管扩张剂，优于双嘧达莫 - 首次通过定量灌注心血管磁共振研究。
J Cardiovasc Magn Reson. 2013 Sep 24;15(1):85. doi: 10.1186/1532-429X-15-85.
6
Impact of integrating heart rate response with perfusion imaging on the prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.将心率反应与灌注成像相结合对终末期肾病患者雷加得诺森单光子发射计算机断层扫描心肌灌注成像预后价值的影响
J Nucl Cardiol. 2017 Oct;24(5):1666-1671. doi: 10.1007/s12350-016-0497-0. Epub 2016 Jun 1.
7
Detection of coronary stenosis with myocardial contrast echocardiography using regadenoson, a selective adenosine A2A receptor agonist.使用瑞加德松（一种选择性的腺苷 A2A 受体激动剂）行心肌声学造影检测冠状动脉狭窄。
Eur Heart J Cardiovasc Imaging. 2012 Apr;13(4):298-308. doi: 10.1093/ejechocard/jer232. Epub 2011 Nov 8.
8
Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.考虑使用雷卡地诺生测量心血管磁共振心肌灌注储备时的注意事项。
J Cardiovasc Magn Reson. 2012 Dec 28;14(1):89. doi: 10.1186/1532-429X-14-89.
9
Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.正常 regadenoson 与正常腺苷心肌灌注成像的预后价值比较：倾向评分匹配研究。
JACC Cardiovasc Imaging. 2012 Oct;5(10):1014-21. doi: 10.1016/j.jcmg.2012.04.009.
10
The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.雷加曲塞单光子发射计算机断层扫描心肌灌注成像在终末期肾病患者中的预后价值。
J Nucl Cardiol. 2017 Feb;24(1):112-118. doi: 10.1007/s12350-015-0303-4. Epub 2015 Nov 18.

引用本文的文献

1
Prevalence of abnormal SPECT myocardial perfusion imaging during the COVID-19 pandemic.新冠疫情期间单光子发射计算机断层扫描心肌灌注成像异常的患病率
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2447-2454. doi: 10.1007/s00259-020-05123-z. Epub 2021 Jan 8.
2
Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2019: Single-photon emission computed tomography.2019 年《核医学杂志》心血管成像综述：单光子发射计算机断层扫描。
J Nucl Cardiol. 2020 Aug;27(4):1171-1179. doi: 10.1007/s12350-020-02167-4. Epub 2020 May 14.
3
Gender-related differences in side-effects and hemodynamic response to regadenoson in patients undergoing SPECT myocardial perfusion imaging.

本文引用的文献

1
Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging.雷加昔布心肌灌注成像中短暂性缺血性扩张的预后价值。
J Nucl Cardiol. 2016 Oct;23(5):1147-1155. doi: 10.1007/s12350-015-0272-7. Epub 2015 Oct 21.
2
Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.雷加得诺森负荷心肌灌注成像时心率反应在终末期肾病患者中的预后价值
J Nucl Cardiol. 2016 Jun;23(3):560-9. doi: 10.1007/s12350-015-0234-0. Epub 2015 Aug 22.
3
Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.
在接受 SPECT 心肌灌注成像的患者中，性别相关的副作用和血液动力学反应差异。
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2590-2600. doi: 10.1007/s00259-019-04463-9. Epub 2019 Aug 14.
4
Indirect evidence of sympathetic stimulation by regadenoson.瑞加德松引起交感神经兴奋的间接证据。
J Nucl Cardiol. 2019 Apr;26(2):684-687. doi: 10.1007/s12350-018-1331-7. Epub 2018 Jun 13.
5
Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes.移植前心肌灌注成像对移植后随访和结局的预测价值。
Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1998-2008. doi: 10.1007/s00259-018-4068-2. Epub 2018 Jun 7.
6
Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.2017 年《核医学杂志》心血管成像述评。第 2 部分，共 2 部分：心肌灌注成像。
J Nucl Cardiol. 2018 Aug;25(4):1390-1399. doi: 10.1007/s12350-018-1266-z. Epub 2018 Apr 16.
7
Adverse effects associated with regadenoson myocardial perfusion imaging.与雷加昔单抗心肌灌注成像相关的不良反应。
J Nucl Cardiol. 2018 Oct;25(5):1724-1731. doi: 10.1007/s12350-018-1218-7. Epub 2018 Feb 21.
8
Myocardial stunning by gated SPECT: An old tool reinvented in a stunning turn.门控单光子发射计算机断层扫描（SPECT）导致的心肌顿抑：一项古老工具的惊人转变。
J Nucl Cardiol. 2019 Jun;26(3):841-844. doi: 10.1007/s12350-017-1127-1. Epub 2017 Nov 14.
9
Risk stratification for renal transplantation: A role for heart rate response?肾移植的风险分层：心率反应起作用吗？
J Nucl Cardiol. 2019 Jun;26(3):823-825. doi: 10.1007/s12350-017-1111-9. Epub 2017 Oct 30.
10
The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation.终末期肾病患者行肾移植时，血管扩张剂应激心肌灌注成像中心率反应的预后价值。
J Nucl Cardiol. 2019 Jun;26(3):814-822. doi: 10.1007/s12350-017-1061-2. Epub 2017 Sep 18.
在高危患者中，连续雷加曲班心肌灌注成像期间灌注缺损大小变化对心血管结局的影响。
J Nucl Cardiol. 2016 Feb;23(1):101-12. doi: 10.1007/s12350-015-0174-8. Epub 2015 May 28.
4
Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging.雷加得诺森与腺苷心肌灌注成像预后价值的比较
J Nucl Cardiol. 2015 Aug;22(4):600-7. doi: 10.1007/s12350-015-0155-y. Epub 2015 May 19.
5
The prognostic value of regadenoson myocardial perfusion imaging.瑞加德松心肌灌注成像的预后价值
J Nucl Cardiol. 2015 Dec;22(6):1214-21. doi: 10.1007/s12350-014-0050-y. Epub 2015 Feb 14.
6
Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction.不同肾功能程度患者中瑞加德松心肌单光子发射计算机断层扫描的预后价值。
Eur Heart J Cardiovasc Imaging. 2014 Aug;15(8):933-40. doi: 10.1093/ehjci/jeu036. Epub 2014 Apr 3.
7
Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET.药理学应激Rb-82 PET时变时性反应受损的预后意义
J Nucl Cardiol. 2014 Apr;21(2):233-44. doi: 10.1007/s12350-013-9820-1. Epub 2014 Jan 31.
8
Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.应用血管扩张剂负荷试验时心率反应对心肌灌注显像正常患者的心血管风险进行重新分类。
Am J Cardiol. 2013 Jan 15;111(2):190-5. doi: 10.1016/j.amjcard.2012.09.013. Epub 2012 Oct 27.
9
Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.正常 regadenoson 与正常腺苷心肌灌注成像的预后价值比较：倾向评分匹配研究。
JACC Cardiovasc Imaging. 2012 Oct;5(10):1014-21. doi: 10.1016/j.jcmg.2012.04.009.
10
The heart rate response to adenosine: a simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetes.腺苷引起的心率反应：2 型糖尿病无症状患者不良心脏结局的简单预测指标。
Int J Cardiol. 2013 Sep 10;167(6):2952-7. doi: 10.1016/j.ijcard.2012.08.011. Epub 2012 Sep 12.